/
Unless the context otherwise requires, all references in this section to SeaStar Medical , the Company , we us or our refer to SeaStar Medical Holding Corporation and our consolidated subsidiaries following the Business Combination (as defined herein), other than certain historical information that refers to the business of SeaStar Medical, Inc. (the Predecessor ) prior to the consummation of t…
The business is unprofitable at the operating level (-986.63% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 814.1% YoY with margins expanding 12229.7pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$1M
▲ +814.1% YoY
Net Income (TTM)
-$12M
▲ +51.1% YoY
Op. Margin
-832.59%
▲ +12229.7pp YoY
ROIC
-113.14%
▲ +279.9pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$14M
▲ +15.0% YoY
Net Debt
-$9M
Net Cash Position
Cash & Equiv.
$9M
Continue Research